FDA Approves New Melanoma Combo, ASH Abstracts Released, Early Ovarian Cancer Data, and More

Vorasidenib Shows Consistent Efficacy With Manageable Safety in IDH1/2-Mutant Diffuse Glioma

Tovorafenib Leads to Durable Off-Treatment Responses in Pediatric BRAF-Altered R/R Low-Grade Glioma

NanO2 Plus Radiation/Temozolomide Is Under Exploration in Newly Diagnosed Glioblastoma

Dr Elder on the Initial Safety Profile of IGV-001 in Newly Diagnosed Glioblastoma